An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 18, 2018

Primary Completion Date

June 3, 2018

Study Completion Date

June 3, 2018

Conditions
Protective Qi Insufficiency
Interventions
DIETARY_SUPPLEMENT

Proglucamune

Following screening and enrollment, participants were treated with 2 tablets of Proglucamune per day for a total duration of 8 weeks. Each Proglucamune tablet contained \~100 mg ß-glucan derived from Baker's Yeast extract (Saccharomyces cerevisiae, cell wall), Reishi mushroom powder (Ganoderma lucidum), and Shitake mushroom powder (Lentinula edodes).

Trial Locations (1)

L3R 5V6

Elegant And Olive Health Clinic, Markham

All Listed Sponsors
collaborator

Elegant And Olive Health Clinic, Canada

OTHER

lead

USANA Health Sciences

INDUSTRY

NCT03829228 - An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency | Biotech Hunter | Biotech Hunter